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Abstract
Introduction: Previous studies using Acute Kidney Injury Network (AKIN)/RIFLE criteria to classify early initiation of
renal replacement therapy (RRT) have defined it as the therapy started in less severe AKIN/RIFLE stages. Generally,
these studies failed in demonstrating measurable benefits.
Methods: We compared RRT initiation in critically ill patients and defined early or late RRT in reference to timing
after stage 3 AKIN was met: patients beginning RRT within 24 hours after acute kidney injury (AKI) stage 3 were
considered early starters. AKIN criteria were evaluated by both urine output (UO) and serum creatinine (sCr) and
patients with acute-on-chronic kidney disease were excluded. A propensity score methodology was used to
control variables.
Results: A total of 358 critically ill patients were submitted to RRT. Only 150 patients with pure AKI at stage 3 were
analyzed. Mortality was lower in the early RRT group (51.5 vs. 77.9%, P = 0.001). After achieving balance between
the groups using a propensity score, there was a significant 30.5 (95% confidence interval [CI] 14.4 to 45.2%, P =
0.002) relative decrease of mortality in the early RRT group. Moreover, patients on the early RRT group had lower
duration of mechanical ventilation, time on RRT and a trend to lower intensive care unit (ICU) length of stay.
Conclusions: For the first time, AKIN was used with UO criterion to evaluate early and late RRT. Using a time-
based approach could be a better parameter to access the association between RRT initiation and outcomes in
patients with AKI.
Introduction
Acute kidney injury is a common occurrence in criti-
cally ill patients, with incidence rates of occurrence
varying from 5 to 60% [1,2] and a trend towards higher
rates (30 to 60%) when using the risk, injury, failure,
loss of kidney function, end stage renal failure (RIFLE)
or Acute Kidney Injury (AKI) Network (AKIN) classifi-
cation. Acute kidney injury is an independent risk factor
for increased morbidity and mortality [3,4]. Renal repla-
cement therapy (RRT) is necessary in about 6% of criti-
cally ill patients, according to a large multinational,
multicenter survey [1]. Generally, RRT is provided as
supportive treatment to AKI patients, preventing addi-
tional disorders (hypervolemia, metabolic acidosis, pro-
gressive uremia, and hyperkalemia).
Data from mainly observational studies have suggested
that early RRT in critically ill patients with AKI may
have a beneficial impact on survival [5,6]. However, in
addition to the lack of large randomized clinical trials
assessing early dialysis indication, there is a broad varia-
tion in the criteria used to classify early or late RRT. In
a review of 16 studies comparing early vs late dialysis,
metabolic markers (serum urea or hyperkalemia) were
the most frequently used parameters (n = 8) [7-13].
Reduced urine output (n = 3) [14-16] or timing from
ICU admission to RRT start (n = 2) [17,18] have also
been used to define early dialysis. RIFLE criteria have
been used in three other studies to define early dialysis
[19-21].
Although the RIFLE criteria were developed and vali-
dated for AKI diagnosis and evaluation of severity, and
not a parameter to guide RRT initiation, some observa-
tional studies [19-21] have investigated whether initiat-
ing RRT in less severe renal injury (that is, RIFLE
* Correspondence: alexandreliborio@yahoo.com.br
1Division of Nephrology, General Hospital of Fortaleza, Rua Ávila Goulart no.
900, 60175-295, Fortaleza, Brazil
Full list of author information is available at the end of the article
Leite et al. Critical Care 2013, 17:R62
http://ccforum.com/content/17/2/R62
© 2013 Leite et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
classification -0 or R) can be associated with a better
survival rate. Although one study that analyzed AKI
after major abdominal surgery demonstrated benefits
[20], two others studies evaluating mainly patients with
sepsis demonstrated similar outcomes with either early
or late RRT [19,21]. However, two problems can make
the analysis of survival benefits in early dialysis difficult
when using this definition: (1) patients at less severe
AKI stages initiating RRT may have severe metabolic
disorders (that is, metabolic acidosis, or hyperkalemia)
in spite of limited renal injury, or even no AKI (RIFLE
classification -0); (2) when using RIFLE/AKIN criteria,
patients with chronic kidney disease (CKD) must have
significant metabolic disorders to require RRT before
classification with the maximum severity grade, as
opposed to those with previous normal previous renal
function. Moreover, no study has evaluated urinary out-
put (UO), making the degree of AKI severity largely
dependent on baseline serum creatinine (sCr), and there
is no information on the timing of RRT initiation after
diagnosis of severe AKI.
In the present study, a different approach using AKI
severity classification was used. Our objective was to
determine whether the timing of RRT earlier or later
than 24 hours after classification as AKIN stage 3, is
associated with hospital mortality in critically ill
patients. Moreover, we excluded acute-on-chronic kid-
ney injury (AKI-CKD) patients.
Materials and methods
This is a retrospective analysis of a prospective cohort of
consecutive critically ill adult patients (> 18 years of age)
undergoing renal replacement therapy. The study was
carried out at referral centers (General Hospital of For-
taleza and Haroldo Juaçaba Hospital) in Fortaleza, Bra-
zil. These hospitals comprise four ICUs with a total of
43 beds. All patients needing RRT from January 2010 to
December 2011 were initially included. We excluded
patients undergoing maintenance RRT, with renal trans-
plantation, with RRT initiated before ICU admission,
those who needed RRT before being classified as AKIN
stage 3 and with an ICU stay of less than 24 h. Patients
who did not have sCr less than or equal to 1.4 mg/dL
during their hospital stay were considered as having pre-
vious CKD and were excluded. This definition was used
instead of glomerular filtration rate (GFR) because it is
the highest level where AKI stage 3 could be diagnosed
by a three-fold increase in reference sCr and not by an
acute increment of 0.5 mg/dL in patients with sCr more
than or equal to 4.0 mg/dL, as discussed below. All
data, including UO at each 6-hour interval, were pro-
spectively collected during the ICU stay by a group of
attendant physicians and nurses after a standardized
database record was implemented. Data preceding ICU
admission were obtained from medical records. We did
not have access to UO data before ICU admission. The
Institutional Ethical Committee of the Hospital Geral de
Fortaleza approved the analysis of data and agreed that
informed consent was unnecessary due to the purely
observational and non-interventional nature of this
study (Resolução CNS 196/96).
Clinical and laboratory parameters
Data variables included demographic characteristics,
comorbidities, surgical or medical ICU admission and
the indications for RRT. Biochemistry data such as com-
plete blood cell count, serum urea (sUr), sCr, blood gas
analyses, serum total bilirubin and serum potassium
were recorded upon ICU admission and RRT initiation.
The clinical parameters and severity score were also
recorded. The clinical parameters included heart rate,
systolic and diastolic blood pressure, partial pressure of
arterial blood gas oxygen and fraction of inspired oxy-
gen. Urine output was measured each 2-hour interval
during the ICU stay. Severity scores included the Glas-
gow Coma Scale (GCS), Acute Physiology and Chronic
Health Evaluation II (APACHE II) score and Simplified
Acute Physiology Score III (SAPS III). The use of
mechanical ventilation and need for vasopressor drugs
were recorded. Definitions were made as follows: hyper-
tension was defined as blood pressure above 140/90
mmHg or use of anti-hypertension agents; diabetes was
defined as previous use of insulin or oral hypoglycemic
agents; sepsis was defined as the presence of both infec-
tion and systemic inflammatory response syndrome [22].
All sCr levels measured from hospital admission until
the start of RRT were recorded. At hospital discharge,
the GFR of survivors was estimated by the CKD-Epide-
miology Collaboration (EPI) equation.
The indications for RRT were: (1) azotemia (sUr >
150 mg/dL) with uremic symptoms; (2) oligoanuria (urine
output < 100 ml every twelve hours) refractory to diure-
tics; (3) hyperkalemia (sK+ > 5.5 mmol/L) refractory to
medical treatment, and (4) metabolic acidosis (pH < 7.2
and serum bicarbonate < 16 m Eq/L in arterial blood gas).
Acute kidney injury classification
Diagnosis and severity of AKI was defined by the AKIN
classification system, using the worst criteria (sCr incre-
ment or reduced UO). The reference sCr was the lowest
achieved during hospital stay before RRT start. Time
from AKI stage 3 diagnosis to RRT start was recorded.
Patients with more than one AKI episode during their
hospital stay had only the first RRT-related AKI episode
recorded. Patients initiating RRT less than 24 h after
reaching AKIN stage 3 were included in the early RRT
group and those after 24 h were included in the late
RRT group.
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Renal replacement therapy modality
Prescription and initiation of RRT was performed by
two groups of nephrologists who did not work with the
present researchers. When patients were receiving vaso-
pressor drugs, sustained low efficiency RRT (SLED) was
performed; otherwise, conventional intermittent hemo-
dialysis was performed. For SLED, the blood flow and
dialysate flow rates were 200 ml/minute and 300 ml/
minute, respectively, and the duration was 8 h. Conven-
tional intermittent hemodialysis was performed for 4 h
with a dialysate flow of 500 ml/minute, and blood flow
of 300 ml/minute. As hemodynamics changed during
the ICU stay, patients changed between RRT modalities.
Outcomes
The endpoint of this study was in-hospital mortality. The
survival period was calculated from RRT initiation to
mortality in non-survivors or to hospital discharge in sur-
vivors. Secondary endpoints included ICU length of stay
(LOS), days on mechanical ventilation and time on RRT.
Statistical analysis
Descriptive statistics are expressed as mean ± SD, or as
absolute frequency and percentage, according to contin-
uous or categorical data, respectively. All variables were
tested for normal distribution using the Kolmogorov-
Smirnov test. The unpaired Student’s t-test was applied
to compare continuous variables and normally distribu-
ted data when appropriate. Categorical data were tested
using the chi-square test.
Kaplan-Meier curves obtained with the log-rank test
were plotted to demonstrate the differences in patient
survival between the two groups (early RRT vs late
RRT). A propensity score methodology was used to con-
trol for bias due to selection of patients placed on early
RRT, using the inverse probability of treatment weight-
ing (IPTW) method. This method has been shown to
have superior performance in estimation of risk differ-
ences in observational studies [23]. First, a propensity
score model included demographic, clinical and labora-
tory data at ICU admission and at the day of RRT start
that could have influenced the decision of placement on
early RRT. This estimated the probability for each study
subject to be placed on early RRT. Then, the contribu-
tion of each subject was weighted by 1/propensity score
for the early RRT group, and by 1/(1-propensity score)
for the delayed late RRT group. These weights assured
that for each combination of the covariates used in the
propensity score model, the sum of the contributions of
all subjects was equal. All pre-RRT variables were
balanced between groups. Covariate balance after the
IPTW weighting was assessed by computing their stan-
dardized differences, and groups were considered
balanced if the standardized differences of all covariates
were < 0.25 [24] and no further adjustment was
required for the outcome analysis. Short-term outcome
variables were compared using IPTW-weighted regres-
sion models. Results were expressed as absolute and
relative average treatment effect. Statistical significance
was set at P < 0.05. Analyses were performed with SPSS
19.0 for Windows and R software version 2.10.1 for
Windows, using the Design and Survey packages [25].
Results
During the study period, 358 patients were submitted to
the ICU for RRT. Overall, 143 were excluded from ana-
lysis. Only 25 patients were excluded because RRT was
initiated before stage 3 AKI was reached. Of the 215
patients available for analysis, 150 had AKI without pre-
vious CKD and 65 had AKI-CKD (Figure 1).
Patients’ characteristics
Overall, the mean age of patients was 55.5 ± 19.1 years
and 84 (57.5%) were male. Most patients (86.0%) were
septic. Overall, in-hospital mortality was 72.0%. Com-
plete clinical and laboratory data are shown in Table 1.
Sixty-four patients (42.6%) were in the early RRT group.
Among patients in the late RRT group, 41 (47.6%)
initiated RRT 24 to 48 h after AKI stage 3 was reached
and 21 (24.4%) after 48 to 72 h.
Patients initiating RRT earlier had lower blood pres-
sure at ICU admission, were more acidotic and had
lower hemoglobin levels. There was a trend towards
RRT initiation due to acidosis in early RRT group and
due to azotemia and hyperkalemia in late RRT group
(Table 1). In-hospital mortality was lower in patients
starting RRT earlier (51.5 vs 77.9%, P = 0.001) (Table 2).
Mortality rates according with early or late RRT were
very similar if patients reached AKI stage 3 first accord-
ing to sCr vs UO criteria (Figure 2). Survival probabil-
ities are shown in Figure 3. The log rank test of Kaplan-
Meier curves showed a significant difference between
groups (log rank P = 0.031). At discharge, no AKI
patient without CKD was RRT-dependent and 18
patients (60.7%) had a GFR > 60 mL/min/1.73 m2.
There was no significant difference between the early
and late RRT groups in GFR at discharge (98.6 ± 37.2
vs 80.1 ± 42.4 mL/min/1.73 m2, respectively, P = 0.349).
Propensity score analysis
The propensity score model included the variables
shown in Table 3. Variables associated with early RRT
at ICU admission were lower systolic blood pressure
and heart rate. On the day of RRT start, higher sCr and
potassium were associated with early RRT initiation.
The propensity score model that resulted in the best
balance between groups included the variables shown in
Table 3.
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The propensity score model had good discrimination
to predict early RRT, c-index = 0.856, good validation
(Hosmer-Lemeshow statistics, P = 0.429), and explained
45% of the variability in the data set (R2 = 0.45). All
demographic, clinical and laboratory variables pre-RRT
were well balanced between groups after IPTW, as
shown in Table 1. Thus, groups were rendered
comparable with regard to all these covariates, and no
further adjustment was required for the outcome analy-
sis. In-hospital mortality, ICU LOS and duration of
mechanical ventilation were the outcome variables that
were comparable between the groups after IPTW
weighting. There was a significant 37.3% relative
decrease in in-hospital mortality in the early RRT group
Figure 1 Patient identification and selection approach. RRT, renal replacement therapy; CKD, chronic kidney disease; AKIN, Acute Kidney
Injury Network; LOS, length of stay.
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compared with the late RRT group (Table 2). Moreover,
a significant reduction was observed in the duration of
mechanical ventilation on a 6-day average, fewer days
on RRT-dependence and a trend toward a decrease in
ICU LOS in the early RRT group.
Discussion
In this study, we evaluated the impact of early RRT on
mortality in critically ill AKI patients. While previous
studies generally used serum urea [8-13] or time from
ICU admission to RRT initiation to characterize early
RRT [17,18], some recent studies have attempted to
define the timing of RRT initiation using RIFLE/AKIN
criteria [19-21]. These recent studies have defined early
RRT started during the initial stages of RIFLE/AKIN
classification. The present study has significant differ-
ences from other studies in evaluating early RRT. First,
we defined early RRT by time (RRT initiating earlier or
later than 24 hours after AKI was diagnosed at its worst
stage). Secondly, we studied a highly homogeneous
population, excluding patients with AKI-CKD, and per-
formed analysis only considering patients who had
Table 1 Patients’ characteristics before and after inverse probability weighting













Age, years 55.5 ± 19.1 54.6 ± 19.7 56.2 ± 18.4 0.08 0.604 0.09 0.586
Sex, male, n (%) 84 (57.5) 35 (54.7) 51 (59.3) 0.09 0.539 0.01 0.960
Diabetes mellitus, n (%) 34 (22.7) 14 (21.9) 20 (23.2) 0.03 0.05 0.812
Hypertension, n (%) 67 (44.7) 27 (42.1) 40 (46.5) 0.09 0.07 0.698
Lower sCr, mg/dL 0.90 ± 0.30 0.96 ± 0.30 0.87 ± 0.29 0.29 0.056 0.03 0.849
Surgical ICU admission, n (%) 27 (18.0) 32 (50) 45 (52.3) 0.04 0.778 0.13 0.409
Sepsis diagnosed, n (%) 129 (86.0) 56 (87.5) 73 (84.9) 0.07 0.648 0.13 0.402
Data at ICU admission
Vasoactive drugs, n (%) 116 (77.3) 49 (76.6) 67 (77.9) 0.03 0.846 0.15 0.338
Systolic blood pressure, mmHg 101.0 ± 22.9 91.8 ± 20.2 108.6 ± 22.5 0.73 0.001 0.17 0.174
Diastolic blood pressure, mmHg 59.4 ± 14.9 55.5 ± 13.4 62.5 ± 15.3 0.13 0.033 0.14 0.201
Heart rate, bpm 101.1 ± 23.5 104.7 ± 21.5 99.3 ± 24.8 0.23 0.160 0.02 0.872
Hemoglobin, g/dL 10.1 ± 2.2 9.8 ± 2.4 10.5 ± 2.1 0.29 0.069 0.14 0.367
White blood cells, x103/mm3 17.0 ± 8.6 15.9 ± 6.6 17.5 ± 7.4 0.07 0.643 0.11 0.659
Platelet count, x103/mm3 230.4 ± 121.7 235.3 ± 131.2 226.4 ± 120.2 0.06 0.724 0.15 0.349
Creatinine, mg/dL 2.11 ± 1.22 2.0 ± 0.9 1.7 ± 0.8 0.04 0.791 0.11 0.357
Urea, mg/dL 78.7 ± 43.1 82.7 ± 44.1 75.4 ± 41.8 0.12 0.481 0.09 0.560
Potassium, mEq/L 4.4 ± 2.1 4.7 ± 1.4 4.2 ± 0.9 0.14 0.394 0.03 0.494
Bicarbonate, mEq/L 17.7 ± 5.7 16.7 ± 5.5 18.5 ± 5.9 0.30 0.071 0.19 0.250
GCS score 12.8 ± 2.7 12.8 ± 3.1 12.8 ± 2.5 0.01 0.986 0.17 0.331
APACHE II score 18.8 ± 6.1 19.2 ± 6.3 18.7 ± 5.9 0.08 0.520 0.03 0.848
SAPS III score 61.1 ± 11.9 62.1 ± 11.7 60.2 ± 12.0 0.15 0.327 0.20 0.227
Data at RRT start
Creatinine, mg/dL 2.93 ± 1.82 2.7 ± 1.1 2.8 ± 1.5 0.04 0.780 0.03 0.855
Urea, mg/dL 106.7 ± 64.8 100.1 ± 54.9 108.2 ± 55.6 0.17 0.461 0.02 0.908
Potassium, mEq/L 5.3 ± 2.0 4.9 ± 1.9 5.1 ± 2.1 0.11 0.499 0.15 0.392
Bicarbonate, mEq/L 16.2 ± 4.4 14.4 ± 3.9 17.2 ± 4.3 0.64 < 0.0001 0.14 0.501
APACHE II score 20.2 ± 6.3 20.3 ± 6.8 20.1 ± 6.2 0.06 0.637 0.05 0.737
SAPS III score 62.6 ± 12.3 63.2 ± 11.8 62.7 ± 11.6 0.10 0.469 0.14 0.298
Indications for dialysis
Azotemia, n (%) 27 (18.0) 7 (10.9) 20 (23.3) 0.34 0.052 0.06 0.715
Oligoanuria, n (%) 118 (78.7) 53 (82.8) 65 (75.6) 0.18 0.285 0.20 0.305
Metabolic acidosis, n (%) 96 (64.0) 46 (71.9) 50 (58.1) 0.29 0.083 0.17 0.358
Hyperkalemia, n (%) 21 (14.0) 4 (6.2) 17 (19.8) 0.41 0.018 0.13 0.402
Results are presented as mean (± SD) unless or number (%) of patients. AKI, acute kidney injury; CKD, chonic kidney disease; RRT, renal replacement therapy GCS,
Glascow Coma Scale; APACHE, Acute Physiology and Chronic Health Evaluation; SAPS, Simplified Acute physiology Score; sCr, serum creatinine; ED, early dialysis;
LD, late dialysis.
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achieved AKI stage 3 before initiating RRT. Lastly,
AKIN criteria were evaluated by either sCr and/or UO
criteria. Using this approach, there was a significant
(37.3%) relative decrease in the mortality rate in patients
subjected to early RRT.
Several studies have used sUr to define early RRT,
with controversial results. In the present study, overall,
pre-RRT sUr was similar to levels among patients in
early RRT in other studies, suggesting all patients were
started relatively early on RRT. Shiao et al. [20] demon-
strated better survival in patients undergoing abdominal
surgery who were submitted to early RRT, defined by
the RIFLE criteria. In the aforementioned study, there
was a trend towards higher blood urea nitrogen (BUN)
in the late RRT group. In the present study, there was
no difference in mean sUr levels between patients with
early or late RRT (Table 2). This finding demonstrates
that early RRT can be associated with better mortality,
regardless of pre-RRT urea levels.
To the best of our knowledge, only three studies have
evaluated early RRT using the AKIN/RIFLE approach
[19-21]. While the previously cited study of patients
undergoing abdominal surgery demonstrated a difference
in survival rates, the two others, which predominantly
included septic patients, were unable to shown any survi-
val benefits of early RRT. When early RRT is defined
only as RRT started at earlier AKI stages (that is, RIFLE
classification -0 or R), these studies can present some
interpretation bias. First, patients with no AKI might be
included. As AKI is associated with poor prognosis in
critically ill patients, the inclusion of these patients can
influence the results. Secondly, patients can achieve a
more severe AKI stage by the UO criterion and erro-
neously remain in the early RRT group. Finally, patients
with previous CKD may need RRT earlier during the
evolution of an AKI episode due to serious metabolic
disorders, mainly when only sCr is available. This can
explain the higher prevalence of CKD patients in the
groups initiating RRT at RIFLE stages -0 or R [20,21].
In our data, fewer patients starting RRT were classified
as AKI stage 3 by sCr. If the UO criterion was not con-
sidered, these patients would be classified at earlier AKI
stages.
In our study, we attempted to eliminate these pitfalls
by separately analyzing only patients in whom CKD
could be excluded (patients with baseline sCR < 1.5 mg/
Table 2 Short-term outcome among the early and delayed RRT groups, before and after inverse probability weighting
of treatment





P-value ED group LD group Average treatment effect
(95% CI)
P-value
Duration of mechanical ventilation, days 12.5 ± 9.8 18.0 ± 13.7 0.049 12.8 ± 7.8 18.9 ± 9.4 -6.02 (-11.50 to -0.54) 0.031
Length of ICU stay, days 18.7 ± 12.5 24.7 ± 17.3 0.093 19.4 ± 11.5 25.4 ± 10.9 -5.97 (-12.91 to 0.976) 0.092
Time on RRT, days 6.9 ± 4.6 8.9 ± 4.6 0.178 6.7 ± 4.9 9.7 ± 6.1 -2.95 (-5.77 to -0.125) 0.041
In-hospital mortality, n (%) 33 (51.5) 67 (77.9) 0.001 51.2 81.7 -30.5 (-14.4 to -45.2) 0.002
Results are presented as mean (± SD) unless stated otherwise. IPTW, inverse probability of treatment weighting; RRT, renal replacement therapy; ED, early dialysis;
LD, late dialysis.
Figure 2 Flowchart of patients achieving Acute Kidney Injury Network stage 3 by serum creatinine or urinary output. AKIN, Acute
Kidney Injury Network; sCr, serum creatinine; UO, urinary output; RRT, renal replacement therapy.
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dL). Moreover, only patients achieving AKI stage 3 were
included, thus selecting a population with the same
degree of AKI severity. Finally, we applied both sCr and
UO criteria. Recorded urine output disclosed that only
25/240 patients were submitted to RRT before AKI
stage 3 was reached. In the study performed by Maccar-
iello et al. [19], 52% of patients initiated RRT at RIFLE
stages -R or I. In both studies by the National Taiwan
University Surgical ICU Associated Renal Failure
(NSARF) study group [20,21], approximately half of the
patients initiated RRT at RIFLE stages -0 or R. It is
probable that these patients would have had more
severe AKI stages if the UO criterion had been applied.
We have defined CKD as an inability to achieve sCr ≤
1.4 mg/dL before RRT. This cutoff was chosen because
it is the highest reference level where AKI stage 3 can
be achieved only by a three-fold increase in sCr criteria
and not by the acute increase of 0.5 mg/dL. This strat-
egy insured that time from renal insult to worst AKI
stage is similar in patients with comparable injury sever-
ity, according to creatinine kinetics as suggested by Wai-
kar and Bonventre [26].
Timing to RRT was measured after patients achieved
AKIN stage 3. We have chosen this method instead of
AKI diagnosis at earlier stages because it seems a more
practical approach. Not all patients with AKI will need
RRT or even progress to AKI stage 3, but it is more
likely patients achieving AKIN stage 3 will need RRT.
As stated by Lameire et al. [27], ‘interpretation of stu-
dies about early or late dialysis is complicated because
there is a loss of the semantic significance of a time-
related event’ and that ‘conclusions on the impact of
early versus late initiation of dialysis would be only justi-
fied when, at the moment patients fulfilled the criteria
for dialysis, one group started RRT immediately while
for the other group dialysis was delayed.’ In the present
methodology, all patients achieved AKI at stage 3 and
RRT was a time-related event. We suggest that one
parameter used to initiate RRT in critically ill patients
can be when stage 3 is reached and renal function
recuperation within a short time has been ruled out.
This does not eliminate the possibility of starting RRT
at early stages when associated with severe metabolic
disorders and/or refractory hypervolemia.
Although showing promising results in terms of per-
forming early RRT in critically ill patients, this study
evaluated only AKIN stage 3, so the influence of RRT
on AKI earlier stages was not evaluated. This limitation
is counterbalanced by considering UO. When using the
UO criterion, many patients classified AKIN 3 would be
otherwise classified AKIN 1 or 2, using only sCr alone.
Including UO criteria could explain why a minority of
patients needed RRT before achieving AKIN stage 3. A
second limitation is that excluding patients who could
Figure 3 Cumulative patient survival between early and late
renal replacement therapy groups. Log rank test, P = 0.031. RRT,
renal replacement therapy.
Table 3 Variables included in the propensity score model along with their estimates and standard errors
Variable Coefficient estimate Standard error P-value
Lowest sCr pre-RRT, mg/d) 1.803 1.341 0.179
Systolic blood pressure at ICU admission, mmHg -0.053 0.021 0.010
Heart rate at ICU admission, bpm -0.054 0.020 0.006
Bicarbonate at ICU admission, mEq/L -0.123 0.073 0.092
Potassium at ICU admission, mEq/L 0.827 0.407 0.042
GCS 0.221 0.145 0.127
SCr pre-RRT, mg/dL 0.442 0.188 0.019
Hyperkalemia pre-RRT 2.358 1.240 0.057
Azotemia 1.629 1.151 0.157
Oligoanuria 1.464 0.966 0.130
sCr, serum creatinine; RRT, renal replacement therapy; GCS, Glascow Coma Scale.
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not achieve a sCr lower than 1.4 mg/dL, might mean
that patients with community-acquired AKI have been
considered as having CKD. In these patients, it would
not be possible to precisely determine when AKI
reached stage 3, making it difficult to classify them into
early or late RRT groups. Another limitation is the lack
of data on fluid balance, making it especially difficult to
explore reasons for reduced mechanical ventilation time
in early RRT patients. Although it is a retrospective
study, we have tried to balance all variables that could
influence the decision to initiate RRT earlier, using the
propensity score and the IPTW method to balance vari-
ables. Finally, the relatively small number of patients is
counterbalanced by the homogeneity of this population,
including only patients with pure AKI.
Conclusions
Using a time-based approach from AKIN stage 3 by UO
or sCr to RRT initiation, this study demonstrated a
reduced mortality rate and reduced need for mechanical
ventilation among critically ill AKI patients receiving
RRT in the first 24 h after diagnosis of AKI stage 3, by
applying both sCr and UO criteria. Patients with AKI-
CKD can influence results of studies that use AKIN/
RIFLE classification to define early RRT. We suggest
that in patients with stage 3 AKI, RRT must be consid-
ered in less than 24 h.
Key messages
• Urinary output is an important criterion for sta-
ging AKI and can be useful in determining the tim-
ing of RRT.
• Patients with previous CKD can influence the
results of studies when classifying early RRT by AKI
stage.
• Performing RRT in the first 24 h of AKIN stage 3
diagnosis reduced in-hospital mortality and mechan-
ical ventilation time.
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